Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Neurosurg Rev. 2023 Mar 15;46(1):70. doi: 10.1007/s10143-023-01976-8.
Patients with brain metastases (BM), who can benefit from resection of multiple scattered lesions, often will not be offered a procedure involving multiple craniotomies in one session due to the overall poor prognosis. However, carefully selected candidates may well benefit from the resection of multiple lesions using multiple craniotomies through a significantly shortened hospital stay, aggressive decompression, and rapid eligibility for adjuvant therapies. In this retrospective analysis, the records of patients, who were treated for multiple BM using one surgical session involving multiple craniotomies, were reviewed. A group of patients with multiple BM, whose surgery only involved one craniotomy, were assigned to a control group. Clinical and surgical characteristics, preoperative and postoperative Karnofsky Performance Scale (KPS), complication rate, preoperative tumor size, number of lesions, number of craniotomies, skin incisions, and intraoperative repositioning of patients were recorded. Thirty-three patients were included in the multiple-craniotomy group. Thirty patients underwent two craniotomies, while three cases involved three craniotomies. Seven patients (21%) were intraoperatively repositioned from a prone to a supine position, which required an average of 23.3 ± 9.3 min from wound closure to the following skin incision. Thirty-six patients with multiple BM and matching characteristics, who received only one craniotomy for the dominant lesion, served as the control group. No difference was detected in postoperative KPS (p = 0.269), complication rate (p = 0.612), rate of new postoperative neurological deficits (p = 0.278), length of intensive care unit (ICU) (p = 0.991), and hospital stay (p = 0.913). There was a significant difference in average preoperative tumor size (p = 0.002), duration of surgery (p < 0.001), and extent of resection (p = 0.002). In the age of personalized medicine, selected patient may benefit from a single surgery for BM using multiple craniotomies. This study shows no significant increase of the perioperative complication rate for surgeries with multiple craniotomies.
患有脑转移瘤(BM)的患者,如果能从多发散在病变的切除中获益,通常由于总体预后较差,不会接受一次手术切除多个病变。然而,精心挑选的患者可能会通过缩短住院时间、积极减压和快速获得辅助治疗的资格,从多次开颅手术切除多个病变中获益。在这项回顾性分析中,回顾了一组接受单次多颅切开术治疗多发 BM 的患者记录。一组仅接受一次开颅手术治疗的多发 BM 患者被分配到对照组。记录了临床和手术特征、术前和术后卡诺夫斯基表现量表(KPS)、并发症发生率、术前肿瘤大小、病变数量、开颅术数量、皮肤切口和术中患者重新定位。33 例患者纳入多颅切开组。30 例患者行 2 次开颅术,3 例患者行 3 次开颅术。7 例(21%)患者从俯卧位重新定位到仰卧位,从关闭伤口到下一个皮肤切口需要平均 23.3±9.3 分钟。36 例具有相似特征的多发 BM 患者,仅对优势病变行 1 次开颅术作为对照组。术后 KPS(p=0.269)、并发症发生率(p=0.612)、新术后神经功能缺损发生率(p=0.278)、重症监护病房(ICU)时间(p=0.991)和住院时间(p=0.913)无差异。术前平均肿瘤大小(p=0.002)、手术时间(p<0.001)和切除程度(p=0.002)有显著差异。在个性化医学时代,选择合适的患者,可能会从多次开颅手术中获益。本研究表明,多次开颅手术的围手术期并发症发生率没有显著增加。